JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.

Saved in:
Bibliographic Details
Title: JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.
Authors: Schnittger, S.1 susanne.schnittger@mll-online.com, Bacher, U.2, Kern, W.1, Haferlach, T.1, Haferlach, C.1
Source: Leukemia (08876924). Aug2007, Vol. 21 Issue 8, p1843-1845. 3p. 2 Charts.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/sj.leu.2404707